Who invested in Spiral Therapeutics?
Spiral Therapeutics's investors include Inveready, Catalio Capital Management, Camden Partners, Savoir Capital and Sunghwan Choi.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$36Mraised across 4 rounds since 2018, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by LifeLink Ventures and 1 otherSEC filing: $27M sold
Reported by FinSMEsSEC filing: $8.5M sold, first sale Dec 2018
From Spiral Therapeutics's own website: 1 founder, 4 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Spiral Therapeutics's investors include Inveready, Catalio Capital Management, Camden Partners, Savoir Capital and Sunghwan Choi.
Spiral Therapeutics has raised $36M across 4 rounds since 2018. One round did not disclose an amount, so the total is a floor.
Spiral Therapeutics's most recent round was a Series B of $27M in Apr 2026.
Its most recent round, $27M in Apr 2026, is also its largest on record.
Spiral Therapeutics's first round on record, in Dec 2018, was backed by Camden Partners and Savoir Capital.
Spiral Therapeutics's latest named round is a Series B, in Apr 2026.
Spiral Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.